Latest / Hematology Highlights with Dr Joshua Richter
Hematology Highlights With Dr Joshua Richter: Episode 2: Treating Multiple Myeloma When T-Cell Redirection Is Not an Option
Dr Joshua Richter reviews multiple myeloma treatment options for patients who are ineligible for or decline T-cell redirection therapy, including CAR T-cell therapy and bispecific antibodies. He discusses alternative therapies for relapsed or refractory multiple myeloma, including belantamab mafodotin, selinexor, venetoclax, cytotoxic chemotherapy, and emerging CELMoDs, with a focus on treatment sequencing, efficacy, and toxicity.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.